Global Gastric Motility Disorder Drug Market Insights, Forecast to 2025

2019-02-01 / 3900.00 / Pharma & Healthcare / 110 Pages

Description

The global Gastric Motility Disorder Drug market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Gastric Motility Disorder Drug market based on company, product type, end user and key regions.

This report studies the global market size of Gastric Motility Disorder Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Gastric Motility Disorder Drug in these regions.
This research report categorizes the global Gastric Motility Disorder Drug market by top players/brands, region, type and end user. This report also studies the global Gastric Motility Disorder Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Theravance, Inc.
Helsinn Healthcare S.A.
Concert Pharmaceuticals, Inc.
Targacept, Inc.
ChironWells GmbH

Market size by Product
Velusetrag
Ipamorelin
TD-8954
Others
Market size by End User
Hospital
Clinic
Home Use

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Gastric Motility Disorder Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Gastric Motility Disorder Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Gastric Motility Disorder Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Gastric Motility Disorder Drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Gastric Motility Disorder Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Gastric Motility Disorder Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Content

Table of Contents

1 Study Coverage
1.1 Gastric Motility Disorder Drug Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Gastric Motility Disorder Drug Market Size Growth Rate by Product
1.4.2 Velusetrag
1.4.3 Ipamorelin
1.4.4 TD-8954
1.4.5 Others
1.5 Market by End User
1.5.1 Global Gastric Motility Disorder Drug Market Size Growth Rate by End User
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Home Use
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Gastric Motility Disorder Drug Market Size
2.1.1 Global Gastric Motility Disorder Drug Revenue 2014-2025
2.1.2 Global Gastric Motility Disorder Drug Sales 2014-2025
2.2 Gastric Motility Disorder Drug Growth Rate by Regions
2.2.1 Global Gastric Motility Disorder Drug Sales by Regions
2.2.2 Global Gastric Motility Disorder Drug Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Gastric Motility Disorder Drug Sales by Manufacturers
3.1.1 Gastric Motility Disorder Drug Sales by Manufacturers
3.1.2 Gastric Motility Disorder Drug Sales Market Share by Manufacturers
3.1.3 Global Gastric Motility Disorder Drug Market Concentration Ratio (CR5 and HHI)
3.2 Gastric Motility Disorder Drug Revenue by Manufacturers
3.2.1 Gastric Motility Disorder Drug Revenue by Manufacturers (2014-2019)
3.2.2 Gastric Motility Disorder Drug Revenue Share by Manufacturers (2014-2019)
3.3 Gastric Motility Disorder Drug Price by Manufacturers
3.4 Gastric Motility Disorder Drug Manufacturing Base Distribution, Product Types
3.4.1 Gastric Motility Disorder Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Gastric Motility Disorder Drug Product Type
3.4.3 Date of International Manufacturers Enter into Gastric Motility Disorder Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Gastric Motility Disorder Drug Sales by Product
4.2 Global Gastric Motility Disorder Drug Revenue by Product
4.3 Gastric Motility Disorder Drug Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Gastric Motility Disorder Drug Breakdown Data by End User

6 North America
6.1 North America Gastric Motility Disorder Drug by Countries
6.1.1 North America Gastric Motility Disorder Drug Sales by Countries
6.1.2 North America Gastric Motility Disorder Drug Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Gastric Motility Disorder Drug by Product
6.3 North America Gastric Motility Disorder Drug by End User

7 Europe
7.1 Europe Gastric Motility Disorder Drug by Countries
7.1.1 Europe Gastric Motility Disorder Drug Sales by Countries
7.1.2 Europe Gastric Motility Disorder Drug Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Gastric Motility Disorder Drug by Product
7.3 Europe Gastric Motility Disorder Drug by End User

8 Asia Pacific
8.1 Asia Pacific Gastric Motility Disorder Drug by Countries
8.1.1 Asia Pacific Gastric Motility Disorder Drug Sales by Countries
8.1.2 Asia Pacific Gastric Motility Disorder Drug Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Gastric Motility Disorder Drug by Product
8.3 Asia Pacific Gastric Motility Disorder Drug by End User

9 Central & South America
9.1 Central & South America Gastric Motility Disorder Drug by Countries
9.1.1 Central & South America Gastric Motility Disorder Drug Sales by Countries
9.1.2 Central & South America Gastric Motility Disorder Drug Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Gastric Motility Disorder Drug by Product
9.3 Central & South America Gastric Motility Disorder Drug by End User

10 Middle East and Africa
10.1 Middle East and Africa Gastric Motility Disorder Drug by Countries
10.1.1 Middle East and Africa Gastric Motility Disorder Drug Sales by Countries
10.1.2 Middle East and Africa Gastric Motility Disorder Drug Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Gastric Motility Disorder Drug by Product
10.3 Middle East and Africa Gastric Motility Disorder Drug by End User

11 Company Profiles
11.1 Theravance, Inc.
11.1.1 Theravance, Inc. Company Details
11.1.2 Company Business Overview
11.1.3 Theravance, Inc. Gastric Motility Disorder Drug Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Theravance, Inc. Gastric Motility Disorder Drug Products Offered
11.1.5 Theravance, Inc. Recent Development
11.2 Helsinn Healthcare S.A.
11.2.1 Helsinn Healthcare S.A. Company Details
11.2.2 Company Business Overview
11.2.3 Helsinn Healthcare S.A. Gastric Motility Disorder Drug Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Helsinn Healthcare S.A. Gastric Motility Disorder Drug Products Offered
11.2.5 Helsinn Healthcare S.A. Recent Development
11.3 Concert Pharmaceuticals, Inc.
11.3.1 Concert Pharmaceuticals, Inc. Company Details
11.3.2 Company Business Overview
11.3.3 Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Products Offered
11.3.5 Concert Pharmaceuticals, Inc. Recent Development
11.4 Targacept, Inc.
11.4.1 Targacept, Inc. Company Details
11.4.2 Company Business Overview
11.4.3 Targacept, Inc. Gastric Motility Disorder Drug Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Targacept, Inc. Gastric Motility Disorder Drug Products Offered
11.4.5 Targacept, Inc. Recent Development
11.5 ChironWells GmbH
11.5.1 ChironWells GmbH Company Details
11.5.2 Company Business Overview
11.5.3 ChironWells GmbH Gastric Motility Disorder Drug Sales, Revenue and Gross Margin (2014-2019)
11.5.4 ChironWells GmbH Gastric Motility Disorder Drug Products Offered
11.5.5 ChironWells GmbH Recent Development

12 Future Forecast
12.1 Gastric Motility Disorder Drug Market Forecast by Regions
12.1.1 Global Gastric Motility Disorder Drug Sales Forecast by Regions 2019-2025
12.1.2 Global Gastric Motility Disorder Drug Revenue Forecast by Regions 2019-2025
12.2 Gastric Motility Disorder Drug Market Forecast by Product
12.2.1 Global Gastric Motility Disorder Drug Sales Forecast by Product 2019-2025
12.2.2 Global Gastric Motility Disorder Drug Revenue Forecast by Product 2019-2025
12.3 Gastric Motility Disorder Drug Market Forecast by End User
12.4 North America Gastric Motility Disorder Drug Forecast
12.5 Europe Gastric Motility Disorder Drug Forecast
12.6 Asia Pacific Gastric Motility Disorder Drug Forecast
12.7 Central & South America Gastric Motility Disorder Drug Forecast
12.8 Middle East and Africa Gastric Motility Disorder Drug Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Gastric Motility Disorder Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer


Table of Figures

List of Tables and Figures

Figure Gastric Motility Disorder Drug Product Picture
Table Gastric Motility Disorder Drug Market Segments
Table Key Manufacturers Gastric Motility Disorder Drug Covered
Table Global Gastric Motility Disorder Drug Market Size Growth Rate by Product 2019-2025 (K Pcs) & (Million US$)
Figure Global Gastric Motility Disorder Drug Sales Market Share by Product 2014-2025
Figure Velusetrag Product Picture
Table Major Manufacturers of Velusetrag
Figure Ipamorelin Product Picture
Table Major Manufacturers of Ipamorelin
Figure TD-8954 Product Picture
Table Major Manufacturers of TD-8954
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Gastric Motility Disorder Drug Market Size Growth Rate by End User 2019-2025 (K Pcs)
Figure Hospital
Figure Clinic
Figure Home Use
Figure Gastric Motility Disorder Drug Report Years Considered
Figure Global Gastric Motility Disorder Drug Market Size 2014-2025 (Million US$)
Figure Global Gastric Motility Disorder Drug Sales 2014-2025 (K Pcs)
Table Global Gastric Motility Disorder Drug Market Size by Regions 2014-2019 (K Pcs) & (Million US$)
Table Global Gastric Motility Disorder Drug Sales by Regions 2014-2019 (K Pcs)
Table Global Gastric Motility Disorder Drug Sales Market Share by Regions 2014-2019
Figure Global Gastric Motility Disorder Drug Sales Market Share by Regions 2014-2019
Figure 2018 Global Gastric Motility Disorder Drug Sales Market Share by Regions
Table Global Gastric Motility Disorder Drug Revenue by Regions 2014-2019 (Million US$)
Table Global Gastric Motility Disorder Drug Revenue Market Share by Regions 2014-2019
Figure Global Gastric Motility Disorder Drug Revenue Market Share by Regions 2014-2019
Figure 2018 Global Gastric Motility Disorder Drug Revenue Market Share by Regions
Table Global Gastric Motility Disorder Drug Sales by Manufacturers (2014-2019) (K Pcs)
Table Global Gastric Motility Disorder Drug Sales Share by Manufacturers (2014-2019)
Figure Global Gastric Motility Disorder Drug Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Gastric Motility Disorder Drug Revenue by Manufacturers (2014-2019) (Million USD)
Table Gastric Motility Disorder Drug Revenue Share by Manufacturers (2014-2019)
Figure Gastric Motility Disorder Drug Value Share by Manufacturers in 2018
Table Key Manufacturers Gastric Motility Disorder Drug Price (2014-2019) (USD/Pcs)
Table Gastric Motility Disorder Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Gastric Motility Disorder Drug Product Type
Table Date of International Manufacturers Enter into Gastric Motility Disorder Drug Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Gastric Motility Disorder Drug Sales by Product (2014-2019) (K Pcs)
Table Global Gastric Motility Disorder Drug Sales Share by Product (2014-2019)
Figure Global Gastric Motility Disorder Drug Sales Market Share by Product (2014-2019)
Figure Global Gastric Motility Disorder Drug Sales Market Share by Product in 2018
Table Global Gastric Motility Disorder Drug Revenue by Product (2014-2019) (Million US$)
Table Global Gastric Motility Disorder Drug Revenue Share by Product (2014-2019)
Figure Global Gastric Motility Disorder Drug Revenue Market Share by Product (2014-2019)
Figure Global Gastric Motility Disorder Drug Revenue Market Share by Product in 2018
Table Gastric Motility Disorder Drug Price by Product 2014-2019 (USD/Pcs)
Table Global Gastric Motility Disorder Drug Sales by End User (2014-2019) (K Pcs)
Table Global Gastric Motility Disorder Drug Sales Share by End User (2014-2019)
Figure Global Sales Gastric Motility Disorder Drug Market Share by End User (2014-2019)
Figure Global Sales Gastric Motility Disorder Drug Market Share by End User in 2018
Figure North America Gastric Motility Disorder Drug Sales Growth Rate 2014-2019 (K Pcs)
Figure North America Gastric Motility Disorder Drug Revenue Growth Rate 2014-2019 (Million US$)
Table North America Gastric Motility Disorder Drug Sales by Countries (2014-2019) (K Pcs)
Table North America Gastric Motility Disorder Drug Sales Market Share by Countries (2014-2019)
Figure 2018 North America Gastric Motility Disorder Drug Sales Market Share by Countries
Table North America Gastric Motility Disorder Drug Revenue by Countries (2014-2019) (Million US$)
Table North America Gastric Motility Disorder Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Gastric Motility Disorder Drug Revenue Market Share by Countries
Figure United States Gastric Motility Disorder Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure United States Gastric Motility Disorder Drug Revenue Growth Rate (2014-2019) (K Pcs)
Figure Canada Gastric Motility Disorder Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Canada Gastric Motility Disorder Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Gastric Motility Disorder Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Mexico Gastric Motility Disorder Drug Revenue Growth Rate (2014-2019) (Million US$)
Table North America Gastric Motility Disorder Drug Sales by Product (2014-2019) (K Pcs)
Table North America Gastric Motility Disorder Drug Sales Market Share by Product (2014-2019)
Figure 2018 North America Gastric Motility Disorder Drug Market Share by Product
Table North America Gastric Motility Disorder Drug Sales by End User (2014-2019) (K Pcs)
Table North America Gastric Motility Disorder Drug Sales Market Share by End User (2014-2019)
Figure 2018 North America Gastric Motility Disorder Drug Market Share by End User
Figure Europe Gastric Motility Disorder Drug Sales Growth Rate 2014-2019 (K Pcs)
Figure Europe Gastric Motility Disorder Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Gastric Motility Disorder Drug Sales by Countries (2014-2019) (K Pcs)
Table Europe Gastric Motility Disorder Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Gastric Motility Disorder Drug Sales Market Share by Countries
Table Europe Gastric Motility Disorder Drug Revenue by Countries (2014-2019) (Million US$)
Table Europe Gastric Motility Disorder Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Gastric Motility Disorder Drug Revenue Market Share by Countries
Figure Germany Gastric Motility Disorder Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Germany Gastric Motility Disorder Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure France Gastric Motility Disorder Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure France Gastric Motility Disorder Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Gastric Motility Disorder Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure UK Gastric Motility Disorder Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Gastric Motility Disorder Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Italy Gastric Motility Disorder Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Gastric Motility Disorder Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Russia Gastric Motility Disorder Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Gastric Motility Disorder Drug Sales by Product (2014-2019) (K Pcs)
Table Europe Gastric Motility Disorder Drug Sales Market Share by Product (2014-2019)
Figure 2018 Europe Gastric Motility Disorder Drug Market Share by Product
Table Europe Gastric Motility Disorder Drug Sales by End User (2014-2019) (K Pcs)
Table Europe Gastric Motility Disorder Drug Sales Market Share by End User (2014-2019)
Figure 2018 Europe Gastric Motility Disorder Drug Market Share by End User
Figure Asia Pacific Gastric Motility Disorder Drug Sales Growth Rate 2014-2019 (K Pcs)
Figure Asia Pacific Gastric Motility Disorder Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Gastric Motility Disorder Drug Sales by Countries (2014-2019) (K Pcs)
Table Asia Pacific Gastric Motility Disorder Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Gastric Motility Disorder Drug Sales Market Share by Countries
Table Asia Pacific Gastric Motility Disorder Drug Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Gastric Motility Disorder Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Gastric Motility Disorder Drug Revenue Market Share by Countries
Figure China Gastric Motility Disorder Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure China Gastric Motility Disorder Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Gastric Motility Disorder Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Japan Gastric Motility Disorder Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Gastric Motility Disorder Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Korea Gastric Motility Disorder Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure India Gastric Motility Disorder Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure India Gastric Motility Disorder Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Gastric Motility Disorder Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Australia Gastric Motility Disorder Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Gastric Motility Disorder Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Indonesia Gastric Motility Disorder Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Gastric Motility Disorder Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Malaysia Gastric Motility Disorder Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Gastric Motility Disorder Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Philippines Gastric Motility Disorder Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Gastric Motility Disorder Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Thailand Gastric Motility Disorder Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Gastric Motility Disorder Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Vietnam Gastric Motility Disorder Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Gastric Motility Disorder Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Singapore Gastric Motility Disorder Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Gastric Motility Disorder Drug Sales by Product (2014-2019) (K Pcs)
Table Asia Pacific Gastric Motility Disorder Drug Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Gastric Motility Disorder Drug Market Share by Product
Table Asia Pacific Gastric Motility Disorder Drug Sales by End User (2014-2019) (K Pcs)
Table Asia Pacific Gastric Motility Disorder Drug Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Gastric Motility Disorder Drug Market Share by End User
Figure Central & South America Gastric Motility Disorder Drug Sales Growth Rate 2014-2019 (K Pcs)
Figure Central & South America Gastric Motility Disorder Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Gastric Motility Disorder Drug Sales by Countries (2014-2019) (K Pcs)
Table Central & South America Gastric Motility Disorder Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Gastric Motility Disorder Drug Sales Market Share by Countries
Table Central & South America Gastric Motility Disorder Drug Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Gastric Motility Disorder Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Gastric Motility Disorder Drug Revenue Market Share by Countries
Figure Brazil Gastric Motility Disorder Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Brazil Gastric Motility Disorder Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Gastric Motility Disorder Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Argentina Gastric Motility Disorder Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Gastric Motility Disorder Drug Sales by Product (2014-2019) (K Pcs)
Table Central & South America Gastric Motility Disorder Drug Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Gastric Motility Disorder Drug Market Share by Product
Table Central & South America Gastric Motility Disorder Drug Sales by End User (2014-2019) (K Pcs)
Table Central & South America Gastric Motility Disorder Drug Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Gastric Motility Disorder Drug Market Share by End User
Figure Middle East and Africa Gastric Motility Disorder Drug Sales Growth Rate 2014-2019 (K Pcs)
Figure Middle East and Africa Gastric Motility Disorder Drug Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Gastric Motility Disorder Drug Sales by Countries (2014-2019) (K Pcs)
Table Middle East and Africa Gastric Motility Disorder Drug Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Gastric Motility Disorder Drug Sales Market Share by Countries
Table Middle East and Africa Gastric Motility Disorder Drug Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Gastric Motility Disorder Drug Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Gastric Motility Disorder Drug Revenue Market Share by Countries
Figure GCC Countries Gastric Motility Disorder Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure GCC Countries Gastric Motility Disorder Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Gastric Motility Disorder Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Turkey Gastric Motility Disorder Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Gastric Motility Disorder Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure Egypt Gastric Motility Disorder Drug Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Gastric Motility Disorder Drug Sales Growth Rate (2014-2019) (K Pcs)
Figure South Africa Gastric Motility Disorder Drug Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Gastric Motility Disorder Drug Sales by Product (2014-2019) (K Pcs)
Table Middle East and Africa Gastric Motility Disorder Drug Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Gastric Motility Disorder Drug Market Share by Product
Table Middle East and Africa Gastric Motility Disorder Drug Sales by End User (2014-2019) (K Pcs)
Table Middle East and Africa Gastric Motility Disorder Drug Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Gastric Motility Disorder Drug Market Share by End User
Table Theravance, Inc. Company Details
Table Theravance, Inc. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Theravance, Inc. Recent Development

Table Helsinn Healthcare S.A. Company Details
Table Helsinn Healthcare S.A. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Helsinn Healthcare S.A. Recent Development

Table Concert Pharmaceuticals, Inc. Company Details
Table Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Concert Pharmaceuticals, Inc. Recent Development

Table Targacept, Inc. Company Details
Table Targacept, Inc. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Targacept, Inc. Recent Development

Table ChironWells GmbH Company Details
Table ChironWells GmbH Gastric Motility Disorder Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table ChironWells GmbH Recent Development

Table Global Gastric Motility Disorder Drug Sales Forecast by Regions 2019-2025 (K Pcs)
Table Global Gastric Motility Disorder Drug Sales Market Share Forecast by Regions 2019-2025
Table Global Gastric Motility Disorder Drug Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Gastric Motility Disorder Drug Revenue Market Share Forecast by Regions 2019-2025
Table Global Gastric Motility Disorder Drug Sales Forecast by Product 2019-2025 (K Pcs)
Table Global Gastric Motility Disorder Drug Sales Market Share Forecast by Product 2019-2025
Table Global Gastric Motility Disorder Drug Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Gastric Motility Disorder Drug Revenue Market Share Forecast by Product 2019-2025
Table Global Gastric Motility Disorder Drug Sales Forecast by End User 2019-2025 (K Pcs)
Table Global Gastric Motility Disorder Drug Sales Market Share Forecast by End User 2019-2025
Figure North America Gastric Motility Disorder Drug Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure North America Gastric Motility Disorder Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Gastric Motility Disorder Drug Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Europe Gastric Motility Disorder Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Gastric Motility Disorder Drug Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Asia Pacific Gastric Motility Disorder Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Gastric Motility Disorder Drug Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Central & South America Gastric Motility Disorder Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Gastric Motility Disorder Drug Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Middle East and Africa Gastric Motility Disorder Drug Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Gastric Motility Disorder Drug Value Chain
Table Gastric Motility Disorder Drug Customers List
Table Gastric Motility Disorder Drug Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Request Sample

* mark fields are compulsory